Long School of Medicine

Drug Target Review: Why PARP inhibitors fail: key role of the CST complex in BRCA1-deficient cancers

<p>Drug Target Review: Why PARP inhibitors fail: key role of the CST complex in BRCA1-deficient cancers</p>

Share This Story